Colony »

Urogen Pharma shares owned by Colony

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Colony from 13F filings

Historical chart of Colony investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by Colony consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by Colony

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.2M 33k 36.80
2026-03-31 $612k 34k 17.98
2025-12-31 $826k 35k 23.42

More positions owned by Colony

Apple (AAPL)
NVIDIA Corporation (NVDA)
Select Sector Spdr Tr St Str Techn Etf (XLK)
Microsoft Corporation (MSFT)
Dimensional Etf Trust Us Cor Equ 2 Etf (DFAC)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Core S&p Ttl Stk (ITOT)
Valued Advisers Tr Kovitz Core Eqt (EQTY)
Ea Series Trust Brid Omn Sma Etf (BSVO)
Broadcom (AVGO)

View all positions for Colony

Top funds holding Urogen Pharma

Rtw Investments
BlackRock
Morgan Stanley
Kynam Capital Management
Leucadia National Corporation
SG Americas Securities
American Century Companies
Acorn Capital Advisors
Point72 Asset Management
Frontier Capital Management
Opaleye Management
Silverarc Capital Management
Menora Mivtachim Holdings
D. E. Shaw & Co
MPM Oncology Impact Management

View all funds holding Urogen Pharma